Transitioning from genotypes to epigenotypes: Why the time has come for medulloblastoma epigenomics

Transitioning from genotypes to epigenotypes: Why the time has come for medulloblastoma epigenomics

Highlights • Medulloblastomas exhibit frequent somatic alterations affecting chromatin modifiers. • Epigenetic profiling provides accurate molecular subgrouping of medulloblastoma. • Epigenome-wide studies using WGBS & ChIPSeq are now being applied to medulloblastoma. • Epigenetic therapy holds...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Neuroscience 2014-04, Vol.264, p.171-185
Hauptverfasser: Batora, N.V, Sturm, D, Jones, D.T.W, Kool, M, Pfister, S.M, Northcott, P.A
Format: Artikel
Sprache:eng
Schlagworte:
Cerebellar Neoplasms - genetics
Child
Epigenesis, Genetic
Epigenomics
Genotype
Humans
Medulloblastoma - genetics
Neurology
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 185
container_issue
container_start_page 171
container_title Neuroscience
container_volume 264
creator Batora, N.V
Sturm, D
Jones, D.T.W
Kool, M
Pfister, S.M
Northcott, P.A
description Highlights • Medulloblastomas exhibit frequent somatic alterations affecting chromatin modifiers. • Epigenetic profiling provides accurate molecular subgrouping of medulloblastoma. • Epigenome-wide studies using WGBS & ChIPSeq are now being applied to medulloblastoma. • Epigenetic therapy holds great promise for the future treatment of medulloblastoma.
doi_str_mv 10.1016/j.neuroscience.2013.07.030
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1519262060</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>1_s2_0_S030645221300612X</els_id><sourcerecordid>1519262060</sourcerecordid><originalsourceid>FETCH-LOGICAL-c374t-598e194262e4109cbcf4884cf723470e33f2b9cee3b73e385d9a7b866c4a4d023</originalsourceid><addsrcrecordid>eNpNkU1r3DAQhkVJ6G7T_oUicsrF7ujDlp1DIIT0AwI9ZEN7E7J2nNXWljaSHdh_Hy2bhOoijXjfd5hnCDlnUDJg9bdt6XGOIVmH3mLJgYkSVAkCPpAla5QoVCXlCVnmn7qQFecL8imlLeRTSfGRLLhoVC04WxK7isYnN7ngnX-kfQwjfUQfpv0OE50CxZ17ry_pn82eThukkxuRbkyiNuRHHyIdcT0PQ-gGk6Ywmjff6Gz6TE57MyT88nqfkYfvt6ubn8Xd7x-_bq7vCiuUnIqqbZC1ktccJYPWdraXTSNtr7iQClCInnetRRSdEiiaat0a1TV1baWRa-DijFwcc3cxPM2YJj26ZHEYjMcwJ80q1uZ0qCFLL49SmzmmiL3eRTeauNcM9AGy3ur_IesDZA1KZ6TZ_PW1z9zlsd-tb1Sz4OoowDzts8Oo7eC8s2b4h3tM2zBHn0FophPXoO8PezqsiQmAmvG_4gV6ApNh</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1519262060</pqid></control><display><type>article</type><title>Transitioning from genotypes to epigenotypes: Why the time has come for medulloblastoma epigenomics</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals</source><creator>Batora, N.V ; Sturm, D ; Jones, D.T.W ; Kool, M ; Pfister, S.M ; Northcott, P.A</creator><creatorcontrib>Batora, N.V ; Sturm, D ; Jones, D.T.W ; Kool, M ; Pfister, S.M ; Northcott, P.A</creatorcontrib><description>Highlights • Medulloblastomas exhibit frequent somatic alterations affecting chromatin modifiers. • Epigenetic profiling provides accurate molecular subgrouping of medulloblastoma. • Epigenome-wide studies using WGBS &amp; ChIPSeq are now being applied to medulloblastoma. • Epigenetic therapy holds great promise for the future treatment of medulloblastoma.</description><identifier>ISSN: 0306-4522</identifier><identifier>EISSN: 1873-7544</identifier><identifier>DOI: 10.1016/j.neuroscience.2013.07.030</identifier><identifier>PMID: 23876321</identifier><language>eng</language><publisher>United States</publisher><subject>Cerebellar Neoplasms - genetics ; Child ; Epigenesis, Genetic ; Epigenomics ; Genotype ; Humans ; Medulloblastoma - genetics ; Neurology</subject><ispartof>Neuroscience, 2014-04, Vol.264, p.171-185</ispartof><rights>IBRO</rights><rights>Copyright © 2013 IBRO. Published by Elsevier Ltd. All rights reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c374t-598e194262e4109cbcf4884cf723470e33f2b9cee3b73e385d9a7b866c4a4d023</citedby><cites>FETCH-LOGICAL-c374t-598e194262e4109cbcf4884cf723470e33f2b9cee3b73e385d9a7b866c4a4d023</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27901,27902</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/23876321$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Batora, N.V</creatorcontrib><creatorcontrib>Sturm, D</creatorcontrib><creatorcontrib>Jones, D.T.W</creatorcontrib><creatorcontrib>Kool, M</creatorcontrib><creatorcontrib>Pfister, S.M</creatorcontrib><creatorcontrib>Northcott, P.A</creatorcontrib><title>Transitioning from genotypes to epigenotypes: Why the time has come for medulloblastoma epigenomics</title><title>Neuroscience</title><addtitle>Neuroscience</addtitle><description>Highlights • Medulloblastomas exhibit frequent somatic alterations affecting chromatin modifiers. • Epigenetic profiling provides accurate molecular subgrouping of medulloblastoma. • Epigenome-wide studies using WGBS &amp; ChIPSeq are now being applied to medulloblastoma. • Epigenetic therapy holds great promise for the future treatment of medulloblastoma.</description><subject>Cerebellar Neoplasms - genetics</subject><subject>Child</subject><subject>Epigenesis, Genetic</subject><subject>Epigenomics</subject><subject>Genotype</subject><subject>Humans</subject><subject>Medulloblastoma - genetics</subject><subject>Neurology</subject><issn>0306-4522</issn><issn>1873-7544</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2014</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpNkU1r3DAQhkVJ6G7T_oUicsrF7ujDlp1DIIT0AwI9ZEN7E7J2nNXWljaSHdh_Hy2bhOoijXjfd5hnCDlnUDJg9bdt6XGOIVmH3mLJgYkSVAkCPpAla5QoVCXlCVnmn7qQFecL8imlLeRTSfGRLLhoVC04WxK7isYnN7ngnX-kfQwjfUQfpv0OE50CxZ17ry_pn82eThukkxuRbkyiNuRHHyIdcT0PQ-gGk6Ywmjff6Gz6TE57MyT88nqfkYfvt6ubn8Xd7x-_bq7vCiuUnIqqbZC1ktccJYPWdraXTSNtr7iQClCInnetRRSdEiiaat0a1TV1baWRa-DijFwcc3cxPM2YJj26ZHEYjMcwJ80q1uZ0qCFLL49SmzmmiL3eRTeauNcM9AGy3ur_IesDZA1KZ6TZ_PW1z9zlsd-tb1Sz4OoowDzts8Oo7eC8s2b4h3tM2zBHn0FophPXoO8PezqsiQmAmvG_4gV6ApNh</recordid><startdate>20140404</startdate><enddate>20140404</enddate><creator>Batora, N.V</creator><creator>Sturm, D</creator><creator>Jones, D.T.W</creator><creator>Kool, M</creator><creator>Pfister, S.M</creator><creator>Northcott, P.A</creator><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20140404</creationdate><title>Transitioning from genotypes to epigenotypes: Why the time has come for medulloblastoma epigenomics</title><author>Batora, N.V ; Sturm, D ; Jones, D.T.W ; Kool, M ; Pfister, S.M ; Northcott, P.A</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c374t-598e194262e4109cbcf4884cf723470e33f2b9cee3b73e385d9a7b866c4a4d023</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2014</creationdate><topic>Cerebellar Neoplasms - genetics</topic><topic>Child</topic><topic>Epigenesis, Genetic</topic><topic>Epigenomics</topic><topic>Genotype</topic><topic>Humans</topic><topic>Medulloblastoma - genetics</topic><topic>Neurology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Batora, N.V</creatorcontrib><creatorcontrib>Sturm, D</creatorcontrib><creatorcontrib>Jones, D.T.W</creatorcontrib><creatorcontrib>Kool, M</creatorcontrib><creatorcontrib>Pfister, S.M</creatorcontrib><creatorcontrib>Northcott, P.A</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Neuroscience</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Batora, N.V</au><au>Sturm, D</au><au>Jones, D.T.W</au><au>Kool, M</au><au>Pfister, S.M</au><au>Northcott, P.A</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Transitioning from genotypes to epigenotypes: Why the time has come for medulloblastoma epigenomics</atitle><jtitle>Neuroscience</jtitle><addtitle>Neuroscience</addtitle><date>2014-04-04</date><risdate>2014</risdate><volume>264</volume><spage>171</spage><epage>185</epage><pages>171-185</pages><issn>0306-4522</issn><eissn>1873-7544</eissn><abstract>Highlights • Medulloblastomas exhibit frequent somatic alterations affecting chromatin modifiers. • Epigenetic profiling provides accurate molecular subgrouping of medulloblastoma. • Epigenome-wide studies using WGBS &amp; ChIPSeq are now being applied to medulloblastoma. • Epigenetic therapy holds great promise for the future treatment of medulloblastoma.</abstract><cop>United States</cop><pmid>23876321</pmid><doi>10.1016/j.neuroscience.2013.07.030</doi><tpages>15</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0306-4522
ispartof Neuroscience, 2014-04, Vol.264, p.171-185
issn 0306-4522
1873-7544
language eng
recordid cdi_proquest_miscellaneous_1519262060
source MEDLINE; Elsevier ScienceDirect Journals
subjects Cerebellar Neoplasms - genetics
Child
Epigenesis, Genetic
Epigenomics
Genotype
Humans
Medulloblastoma - genetics
Neurology
title Transitioning from genotypes to epigenotypes: Why the time has come for medulloblastoma epigenomics
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-13T20%3A43%3A07IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Transitioning%20from%20genotypes%20to%20epigenotypes:%20Why%20the%20time%20has%20come%20for%20medulloblastoma%20epigenomics&rft.jtitle=Neuroscience&rft.au=Batora,%20N.V&rft.date=2014-04-04&rft.volume=264&rft.spage=171&rft.epage=185&rft.pages=171-185&rft.issn=0306-4522&rft.eissn=1873-7544&rft_id=info:doi/10.1016/j.neuroscience.2013.07.030&rft_dat=%3Cproquest_cross%3E1519262060%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1519262060&rft_id=info:pmid/23876321&rft_els_id=1_s2_0_S030645221300612X&rfr_iscdi=true